Ground-breaking milestone in Head & Neck cancer treatment achieved
Scandinavian ChemoTech announces pivotal achievements when the Ethics Committee, at the University Hospital in Jodhpur, greenlights protocol amendment to the Head & Neck Cancer (HNC) study to include Tumour Specific Electroporation (TSE) in earlier curative lines and the first patients has been treated.The approved protocol amendment positions TSE within the earlier curative lines of therapy for patients with head & neck cancer. It represents a paradigm shift in our field of medicine, bringing TSE to the forefront of curative interventions for these indications. This strategic move marks an